(Health-NewsWire.Net, August 26, 2016 ) Parecoxib is a kind of COX-2 inhibitor which compared with opioid, can effectively inhibit COX-2 expression and reduce the synthesis of prostaglandin in the central and peripheral nervous system, inhibit hyperalgesia and increase pain threshold. Parecoxibs analgesia has been confirmed in studies conducted by anesthesia department, department of orthopaedics, gynecology and general surgery department. And its combination of fast lasting pain relief and safety has made it a better choice for postoperational analgesia.
Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to enter Europe under the trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. Parecoxib develops fast after entering China in 2008. According to CRIs market survey, its annual sales value rose from less than CNY 20 million in 2008 to over CNY 200 million in 2014 with CAGR during this period reaching 54.70%. Currently, parecoxib in the Chinese market is monopolized by Upjohn that brought in a sales value of CNY 204 million in 2014. It is possible for local parecoxib to come into the market in the next few years. And the market size of parecoxib in China is expected to keep growing. Request sample at : https://marketreportscenter.com/request-sample/133423
Readers can get at least the following information from this report: -market size of parecoxib in China -competitive landscape of parecoxib in Chinese market -price of parecoxib made by different enterprises in China -market outlook of parecoxib in China
Check for Discount at : https://marketreportscenter.com/request-discount/133423 The author suggests the following groups of people purchase this report: -manufacturers of analgesic -investors/ research institutions interested in Chinese medicine market -any interest in the Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133423/investigation-report-on-china-parecoxib-market-2010-2019
Connect for more details: Sam Collins Market Reports Center Call us : 1-646-883-3044 (US) Email : info@marketreportscenter.com visit our website : https://marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com
|